The medical and academic community in Stockholm is mourning the passing of Dr. Hannes Hagström, a respected hepatologist and professor at Karolinska Institutet. His death at the age of 45 has been met with deep sorrow across the global medical and scientific community.
Dr. Hagström was internationally recognized for his groundbreaking research in liver disease, particularly metabolic dysfunction-associated steatotic liver disease (MASLD) and liver fibrosis. His work significantly contributed to advancing understanding of liver disease progression and improving clinical approaches to patient care.
He was widely respected for his academic contributions and clinical expertise, including his role in shaping international guidelines in hepatology. He was also a recipient of the UEG Rising Star 2024 award, reflecting his influence and leadership within the global gastroenterology and hepatology community.
Colleagues, students, and collaborators remember him as intelligent, humble, and deeply committed to mentorship. He was known for his generosity in guiding younger researchers and his passion for advancing evidence-based medicine, leaving a lasting mark on those he worked with.
As the scientific community continues to grieve his loss, Dr. Hannes Hagström is being remembered for his exceptional contributions to medicine, his compassion for patients, and his enduring legacy in research and education.
About the Author
